| scholarly article | Q13442814 |
| P2093 | author name string | Seungyoon Nam | |
| P2860 | cites work | ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context | Q21284234 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis | Q24297829 | ||
| RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation | Q24320064 | ||
| The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists | Q24643720 | ||
| A census of human cancer genes | Q24647081 | ||
| Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma | Q26827104 | ||
| Immunotherapy in gastric cancer | Q27010472 | ||
| Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs | Q27726998 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer. | Q27853393 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia | Q28257366 | ||
| Interferons, immunity and cancer immunoediting | Q28270336 | ||
| Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation | Q29614227 | ||
| Topological analysis and interactive visualization of biological networks and protein structures | Q30414346 | ||
| Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens | Q31171461 | ||
| VEGF targets the tumour cell | Q33573324 | ||
| Getting Syk: spleen tyrosine kinase as a therapeutic target. | Q33993750 | ||
| clusterMaker: a multi-algorithm clustering plugin for Cytoscape | Q34070756 | ||
| Janus kinases: components of multiple signaling pathways | Q34103659 | ||
| Pathway-based evaluation in early onset colorectal cancer suggests focal adhesion and immunosuppression along with epithelial-mesenchymal transition | Q34229772 | ||
| PATHOME: an algorithm for accurately detecting differentially expressed subpathways | Q34276504 | ||
| An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells | Q34523785 | ||
| An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer | Q34609329 | ||
| Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. | Q34809019 | ||
| Network analyses in systems pharmacology | Q34995155 | ||
| Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells | Q35110418 | ||
| RSK1 activation promotes invasion in nodular melanoma. | Q35143744 | ||
| HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer | Q36475493 | ||
| Establishing the role of tyrosine kinase 2 in cancer | Q36643671 | ||
| Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies | Q37175089 | ||
| AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer | Q37414462 | ||
| The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer | Q37588281 | ||
| Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution | Q38257912 | ||
| The kinome 'at large' in cancer | Q38715428 | ||
| Meta-Analysis in Gene Expression Studies | Q38786237 | ||
| Toward a Reference Gene Catalog of Human Primary Monocytes. | Q38797067 | ||
| Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma. | Q38819065 | ||
| Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy | Q38995507 | ||
| Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways. | Q39051702 | ||
| A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity | Q39133025 | ||
| LAT-1 functions as a promotor in gastric cancer associated with clinicopathologic features | Q39133742 | ||
| Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells | Q40489621 | ||
| The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer | Q42704069 | ||
| Ten years of anti-vascular endothelial growth factor therapy | Q46407140 | ||
| Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer | Q46898080 | ||
| VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival | Q50883768 | ||
| The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer | Q50886906 | ||
| MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. | Q51689102 | ||
| Computing topological parameters of biological networks | Q51900389 | ||
| Mechanisms of drug combinations: interaction and network perspectives | Q83265745 | ||
| Network biology: why do we need hubs? | Q83859951 | ||
| P433 | issue | 4 | |
| P921 | main subject | transcriptome | Q252857 |
| P304 | page(s) | 217-224 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | OMICS A Journal of Integrative Biology | Q15753054 |
| P1476 | title | Cancer Transcriptome Dataset Analysis: Comparing Methods of Pathway and Gene Regulatory Network-Based Cluster Identification | |
| P478 | volume | 21 |
Search more.